Aura Biosciences, Inc. (AURA) Operating cash flow 2020–2025
Aura Biosciences, Inc. (AURA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$84.7MFY2025 · since FY2020: -$24.3M → -$84.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$84.7M | -6.2% |
| FY2024 | -$79.8M | -25.0% |
| FY2023 | -$63.8M | -16.9% |
| FY2022 | -$54.6M | -68.5% |
| FY2021 | -$32.4M | -33.3% |
| FY2020 | -$24.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AURA financial trends
AURA RevenueAURA Net incomeAURA Net marginAURA Gross profitAURA Gross marginAURA Operating incomeAURA Operating marginAURA Free cash flowAURA Capital expendituresAURA Return on equityAURA Stock buybacksAURA Dividends paidAURA Total assetsAURA Total liabilitiesAURA Shareholders’ equityAURA overview →